Medical News

RSS

DNA methylation signature marks recurrence in early stage lung cancer

An international research team has identified a DNA methylation signature that identifies patients with stage I non-small-cell lung cancer who are at high risk for relapse.

31 Oct 2013

Self-harm warns of repeated suicide attempt risk in schizophrenia

Individuals who have attempted suicide and also have a history of self-harm should be thoroughly assessed for psychotic symptoms in order to prevent delayed treatment and the risk for repeated suicide attempts, say researchers.

31 Oct 2013

Large, rare CNV burden reduced in bipolar disorder

Large and rare chromosomal copy number variants are uncommon in patients with bipolar disorder, even those with early-onset disease, study findings confirm.

31 Oct 2013

Toxicity limits benefits of bevacizumab–erlotinib NSCLC maintenance therapy

Two targeted anticancer drugs used together after first-line chemotherapy for advanced stage non-small-cell lung cancer improve progression-free survival, the results of a large, prospective study show.

31 Oct 2013

Interim data from Phase 1B trial of an investigational anti-PD-1 immunotherapy in patients with previously-treated NSCLC announced by Merck

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Edward Garon, Director of Thoracic Oncology, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, at the 15th World Conference on Lung Cancer in Sydney, Australia (Abstract #2416).

31 Oct 2013

COMS OPAL Award program recognizes top performers on a national basis

COMS Interactive, also known as Clinical Outcomes Management Systems, has launched the Outcomes Performance Achievement Leader (OPAL) Award program. The program is an extension of the company's focus on improving health care and clinical outcomes in the long-term care marketplace by leveraging Daylight IQ™, the COMS' flagship Disease Management Product Suite.

31 Oct 2013

Avidus Management Group provides market guidance relating to acquisition strategy

Avidus Management Group Inc. ("Avidus" or the "Company"), today provided market guidance relating to its acquisition strategy.

31 Oct 2013

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Crown serves pharmaceutical companies and biotech companies. We have two areas of focus: oncology and metabolic diseases. In the oncology space we focus on pre-clinical services. Essentially, we have all the tools to help our customers move from target discovery, target validation, to a clinical candidate.

31 Oct 2013

New therapeutic approach for treating type 2 diabetes

Scientists from the Helmholtz Zentrum München (HMGU) and the Technische Universität München (TUM), together with scientists in the USA, have developed a new therapeutic approach for treatment of type 2 diabetes.

31 Oct 2013

Cardinal Health's non-GAAP operating earnings increase 13% to $532M in Q1 FY 2014

Cardinal Health today reported fiscal year 2014 first-quarter revenue of $24.5 billion and a 36 percent increase in non-GAAP diluted earnings per share (EPS) from continuing operations to $1.10. Non-GAAP operating earnings increased 13 percent to $532 million.

31 Oct 2013

Cigna posts strong revenue growth in third quarter 2013

Cigna Corporation today reported strong third quarter 2013 results with each of the Company's business segments posting strong revenue and earnings contributions.

31 Oct 2013

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Array BioPharma Inc. today reported results for the first quarter of its fiscal year ending June 30, 2014.

31 Oct 2013

Actavis seeks FDA approval to market Isotretinoin Capsules

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Isotretinoin Capsules, 10 mg, 20 mg, 30 mg and 40 mg.

31 Oct 2013

Researchers identify new way to determine successful surgical outcomes for epilepsy

A discovery from Case Western Reserve and Cleveland Clinic researchers could provide epilepsy patients invaluable advance guidance about their chances to improve symptoms through surgery.

31 Oct 2013

New collaborative effort to fight cancer

To defeat cancer it takes a team effort. Southeast Michigan headquartered advertising agency, DBA Worldwide, united Detroit's ultimate team: NFL's Detroit Lions and Henry Ford Health System, to make a difference in Michigan's fight against cancer.

31 Oct 2013

Kyruus, University Hospitals partner to deploy Providermatch solution to optimize patient access

Kyruus, a leading provider of Patient Access & Referral Management Solutions, announced today that it has partnered with University Hospitals in Cleveland, Ohio, to deploy its ProviderMatch platform.

31 Oct 2013

INTEGRA launches new single-use waste collection bottles for its VACUSIP benchtop aspiration system

INTEGRA has launched new single-use waste collection bottles for its VACUSIP benchtop aspiration system – a compact, portable solution for safe and convenient disposal of small volumes of biological liquid waste.

From INTEGRA Biosciences 31 Oct 2013

VG Life Sciences' peptide awarded US patent for HIV treatment

The United States Patent and Trademark Office has issued on October 15, 2013 Patent No.: US 8,557,764 covering the VG Life Sciences' peptide VG1177 for treating HIV infection.

31 Oct 2013

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Valeant Pharmaceuticals International, Inc. announces third quarter financial results for 2013. "Despite an unexpected early launch of a generic Retin-A Micro, significant headwinds this quarter from foreign exchange movements, and the demands of a major integration, we managed to beat expectations and position Valeant for a terrific fourth quarter and a strong 2014," stated J. Michael Pearson, chairman and chief executive officer.

31 Oct 2013

Advanced inventory management systems can reduce costs related to medical, surgical items

Health-care supply chain researchers at the University of Arkansas, in a study of three hospitals within the Mercy network, have found that adoption of advanced inventory management systems can significantly reduce costs associated with medical and surgical items used in operating rooms.

31 Oct 2013

Medical News

DNA methylation signature marks recurrence in early stage lung cancer

Self-harm warns of repeated suicide attempt risk in schizophrenia

Large, rare CNV burden reduced in bipolar disorder

Toxicity limits benefits of bevacizumab–erlotinib NSCLC maintenance therapy

Interim data from Phase 1B trial of an investigational anti-PD-1 immunotherapy in patients with previously-treated NSCLC announced by Merck

COMS OPAL Award program recognizes top performers on a national basis

Avidus Management Group provides market guidance relating to acquisition strategy

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

New therapeutic approach for treating type 2 diabetes

Cardinal Health's non-GAAP operating earnings increase 13% to $532M in Q1 FY 2014

Cigna posts strong revenue growth in third quarter 2013

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Actavis seeks FDA approval to market Isotretinoin Capsules

Researchers identify new way to determine successful surgical outcomes for epilepsy

New collaborative effort to fight cancer

Kyruus, University Hospitals partner to deploy Providermatch solution to optimize patient access

INTEGRA launches new single-use waste collection bottles for its VACUSIP benchtop aspiration system

VG Life Sciences' peptide awarded US patent for HIV treatment

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Advanced inventory management systems can reduce costs related to medical, surgical items

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News